Historically the central nervous system (CNS) has been viewed as a relatively immune sheltered tissue. Under physiological conditions the CNS is devoid of leukocytes, including professional antigen presenting cells (APC), is deficient in key immune accessory molecules such as major histocompatibility molecules (MHC) and is protected by an effective blood brain barrier. Significantly, however, in numerous pathological states including infectious diseases and autoimmune disorders (e.g. multiple sclerosis) immune cells are effectively recruited to and infiltrate in the CNS. This immune response can be a two-edged sword required on the one hand to control infection and facilitate tissue repair and regeneration but on the other causing tissue injury that can result in life threatening complications. Therefore, understanding the mechanisms that control the trafficking of leukocytes to the CNS and the subsequent interactions between these cells that contribute to tissue injury has significant implications.
Chapter PDF
Similar content being viewed by others
Keywords
- Central Nervous System
- Transgenic Mouse
- Experimental Autoimmune Encephalomyelitis
- Chemokine Receptor
- Myelin Basic Protein
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Müller, M., Campbell, I.L. (2008). Chemokine Actions in the CNS: Insights from Transgenic Mice. In: Lane, T.E., Carson, M., Bergmann, C., Wyss-Coray, T. (eds) Central Nervous System Diseases and Inflammation. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-73894-9_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-73894-9_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-73893-2
Online ISBN: 978-0-387-73894-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)